New to Meducation?
Sign up
Already signed up? Log In

Resources

Category

Preview
0
7

How Wellcome and Gates Charities Profit From Helping Biotech

The Wellcome Trust medical charity is to profit from U.S. approval of a new diagnostic cancer test, the first commercial product funded by the organization since the sale of its pharmaceuticals business to Glaxo in 1995.  
medscape.com
over 4 years ago
Preview
0
9

New Incentives Needed to Develop Antibiotics to Fight Superbugs

Drugmakers are renewing efforts to develop medicines to fight emerging antibiotic-resistant bacteria, but creating new classes of drugs on the scale needed is unlikely to happen without new financial incentives to make the effort worth the investment.  
medscape.com
over 4 years ago
Preview
0
0

Obesity Halves Chance for RA Remission, Study Suggests

Patients with rheumatoid arthritis who were obese were only about half as likely to achieve and sustain RA remission as nonobese patients.  
medscape.com
over 4 years ago
3
0
2

Loading...

 
neuronation.com
over 4 years ago
Preview
0
0

Relationships between biomedical companies and guideline makers are often undisclosed

Financial relationships between organisations that produce clinical guidelines and biomedical companies are common and often not disclosed in the guidelines, according to research published in PLOS Medicine.1  
feeds.bmj.com
over 4 years ago
Preview
0
6

Ecstasy is making a comeback, European drugs report warns

Methylenedioxymethamfetamine (MDMA), most commonly used in the form of “ecstasy” tablets, is returning as a stimulant drug of choice for young people in Europe, stated the European Monitoring Centre for Drugs and Drug Addiction in its annual report presented in Lisbon, Portugal, on 31 May.1  
feeds.bmj.com
over 4 years ago
Preview
0
8

Prenatal Fish Oil and IgE-Associated Allergies in Children

Taking fish oil supplements during pregnancy has no effect on a child's IgE-associated allergies, Australia-based researchers report.  
medscape.com
over 4 years ago
Preview
0
7

Early TAVR Device Durability Comes Under Scrutiny

Up to half of first-generation transcatheter aortic-valve devices degenerated within 8 years, but experts say the real question is, "Are there differences between surgical valves and TAVI valves?"  
medscape.com
over 4 years ago
Preview
0
1

Could Flu Shots Lower Hospitalization, Dementia Risk in HF?

One study showed a 35% lower dementia risk, whereas another "provides the most compelling evidence to date for the protective effect of influenza vaccination on hospital admissions," say researchers.  
medscape.com
over 4 years ago
Preview
0
5

Update on HCV Guidelines CME

This activity was developed for gastroenterologists, hepatologists, infectious disease (ID)/Human immunodeficiency virus (HIV) specialists, primary care physicians, and other healthcare providers managing patients with hepatitis C virus (HCV).  
medscape.org
over 4 years ago
Preview
0
4

FDA OKs Linagliptin/Metformin Combo for Type 2 Diabetes

Approval is for the treatment of adults with type 2 diabetes as adjunct to diet and exercise.  
medscape.com
over 4 years ago
Preview
0
13

Remission Common in British Kidney Disease Patients

Remission of chronic kidney stage 3 disease is as common as progression, at least in primary care patients treated in the United Kingdom, new research shows.  
medscape.com
over 4 years ago
Preview
0
6

The Two-Sided Issue of Colorectal Cancer

Dr David Kerr previews key colorectal cancer abstracts from ASCO 2016 that range from combinations of checkpoint inhibitors to the prognostic value of tumor location.  
medscape.com
over 4 years ago
Preview
0
0

GnRH Agonist Fails to Save Fertility in Lymphoma Patients

After 5 years of follow-up, GnRHa treatment did not prevent chemotherapy-induced premature ovarian failure in young women with lymphoma, a result that contrasts with findings from other studies.  
medscape.com
over 4 years ago
Preview
0
1

Findings From NEMO, and Other Melanoma Highlights

In a preview of ASCO melanoma studies, the NEMO results suggest that binimetinib is reasonable for NRAS-mutated melanoma, and combo regimens continue to show strong outcomes, reports Dr Jeffrey Weber.  
medscape.com
over 4 years ago
Preview
0
3

FDA Approves Diagnostic Agent for Recurrent Prostate Cancer

The FDA has approved fluciclovine (18F), an injectable radioactive diagnostic agent that is used to detect recurrent prostate cancer.  
medscape.com
over 4 years ago
Preview
0
2

Cannabis Extract Spray Reduces Spasticity in Patients With MND

Italian researchers report positive results from a phase 2 randomized controlled trial of patients with motor neuron diseases, including ALS.  
medscape.com
over 4 years ago
Preview
0
0

FDA Clears Obeticholic Acid for Primary Biliary Cholangitis

The first new treatment in almost 20 years for the condition, Ocaliva is for use in combination with UDCA in adults with poor response to UDCA or as a single therapy in adults unable to tolerate UDCA.  
medscape.com
over 4 years ago
Preview
0
8

Motor neurone disease patients 'face delays in seeing specialists' - BBC News

One in five people with motor neurone disease waits more than a year to see a brain specialist for help with diagnosis, a snapshot survey by the MND Association suggests.  
bbc.co.uk
over 4 years ago
Preview
0
0

Could a Prior Pregnancy Termination Increase Preterm Delivery Risk?

Dr Peter Kovacs reviews a meta-analysis that evaluated the impact of prior pregnancy termination on subsequent risk for preterm delivery.  
medscape.com
over 4 years ago